Azurity Pharmaceuticals, Inc. is a privately held specialty pharmaceutical company focused on the needs of patients, especially children and the elderly, that require customized user-friendly drug formations.
Our products have benefited millions of patients whose needs are not served by other commercially available therapies.
AZURITY VALUES:
COMPASSION - We put the needs of our patients and caregivers at the center of everything we do, including the decisions we make.
QUALITY - We aim to provide our patients with the highest-quality, safe, and effective therapies for their needs.
INNOVATION - We use the best science and manufacturing techniques to deliver cost-effective, high-value medications to our patients.
A COMPANY OF DIFFERENCE MAKERS
As Azurity grows to meet new challenges, and serve new patient groups, one thing never changes: our dedication to the lives of others.
Whether through our innovative medications, our focus on creating a positive company environment, or our community and volunteer work, we are committed to having a positive impact on the lives of those we touch.
Our products have benefited millions of patients whose needs are not served by other commercially available therapies.
AZURITY VALUES:
COMPASSION - We put the needs of our patients and caregivers at the center of everything we do, including the decisions we make.
QUALITY - We aim to provide our patients with the highest-quality, safe, and effective therapies for their needs.
INNOVATION - We use the best science and manufacturing techniques to deliver cost-effective, high-value medications to our patients.
A COMPANY OF DIFFERENCE MAKERS
As Azurity grows to meet new challenges, and serve new patient groups, one thing never changes: our dedication to the lives of others.
Whether through our innovative medications, our focus on creating a positive company environment, or our community and volunteer work, we are committed to having a positive impact on the lives of those we touch.
Location: United States, Massachusetts, Woburn
Employees: 201-500
Founded date: 2000
Investors 1
| Date | Name | Website |
| - | NovaQuest ... | novaquest.... |
Mentions in press and media 7
| Date | Title | Description |
| 03.03.2026 | Azurity Pharmaceuticals, Inc. - 656489 - 03/24/2026 | Reference #: FEI 3003395329 Product: Drugs Recipient: Recipient Name Mr. Ronald Scarboro Azurity Pharmaceuticals, Inc. 900 Ridgefield Drive Raleigh, NC 27609 United States rscarboro@azurity.com Issuing Office: Center for Drug Evaluation and... |
| 19.11.2025 | ACA Pharma Announces 2026 China NPP Group Procurement Priority List for Orphan and Clinically Urgent Drugs | Hospital alliance spanning 44 pediatric and 45 Greater Bay Area hospitals, plus top rare-disease centers in Beijing, Shanghai, Tianjin, Chongqing and Hainan, identifies highest-priority therapies for fast access via China Group NPP and Maca... |
| 18.11.2025 | Azurity Pharmaceuticals and Sebela Pharmaceuticals Announce the Sale of Sebela’s Bowel Prep Franchise to Azurity | Azurity Pharmaceuticals and Sebela Pharmaceuticals Announce the Sale of Sebela’s Bowel Prep Franchise to Azurity This Strategic Transaction Expands Azurity’s Existing Gastrointestinal Portfolio Woburn, MA – November 17, 2025 – Azurity Pharm... |
| 23.10.2025 | ACA Pharma Named Exclusive Distributor for Feraheme® in Hong Kong, Macau, Greater Bay Area, Mainland China, and Singapore | ACA Pharma Named Exclusive Distributor for Feraheme® in Hong Kong, Macau, Greater Bay Area, Mainland China, and Singapore NEW YORK, Oct. 23, 2025 /PRNewswire-PRWeb/ -- ACA Pharma and Azurity Pharmaceuticals are pleased to announce that they... |
| 15.03.2025 | Mergers and Acquisitions: The Dance of Growth in Global Markets | In the world of business, mergers and acquisitions are like a high-stakes dance. Companies twirl and spin, seeking partners that can elevate their performance. Recently, two significant deals have captured attention: Norva24's takeover by A... |
| 14.03.2025 | Azurity Pharmaceuticals Completes Acquisition of Covis Pharma | WOBURN, Mass., March 14, 2025 /PRNewswire/ -- Azurity Pharmaceuticals ("Azurity") announced today the successful completion of its acquisition of Covis Group S.à r.l. ("Covis") from existing investors. With this acquisit... |
| 09.02.2021 | Azurity Pharmaceuticals Announces Three New Neurology Products |